Cite

HARVARD Citation

    De Vita, F. et al. (2016). NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice. BMC cancer. 16 (1), pp. 1-8. [Online]. 
  
Back to record